Tech Center 1600 • Art Units: 1641 1642
This examiner grants 39% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18362410 | IMMUNOMODULATORY PROTEINS AND RELATED METHODS | Final Rejection | Flagship Pioneering Innovations VII, LLC |
| 18006294 | METHODS FOR THE USE OF A PD-1 X CTLA-4 BISPECIFIC MOLECULE | Non-Final OA | MACROGENICS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy